Sale!

Autoimmune Interstitial Lung Disease ILD Panel Test Cost

Original price was: 2,360 د.إ.Current price is: 2,120 د.إ.

-10%

Autoimmune Interstitial Lung Disease (ILD) Panel Test is a diagnostic evaluation aimed at identifying autoimmune disorders that affect the lungs, leading to interstitial lung disease. This condition encompasses a group of diseases causing progressive scarring (fibrosis) of lung tissue, which can significantly impact lung function and overall health. The panel test looks for specific antibodies and markers in the blood that are associated with autoimmune ILDs, helping in the differentiation from other types of lung diseases and guiding appropriate treatment strategies.

The test cost is set at 2120 AED and is conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic services and state-of-the-art laboratory technologies. The lab provides accurate, reliable results, supporting healthcare professionals in making informed decisions regarding patient care. This test is particularly important for individuals presenting symptoms of ILD, such as shortness of breath and chronic cough, as early detection and correct diagnosis can greatly affect the management and prognosis of the disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AUTOIMMUNE INTERSTITIAL LUNG DISEASE ILD PANEL Test

Test Name: AUTOIMMUNE INTERSTITIAL LUNG DISEASE ILD PANEL Test

Components:

  • ANA / ANF, IFA (HEP-2) Reflex to ENA Profile
  • ANCA, IFA in dilutions
  • ANTI CCP
  • RA factor, serum
  • ACE

Price: 2120.0 AED

Sample Condition: 3 mL (2 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery: Sample Mon through Sat by 11 am; Report Next day

Method: CMIA, IFA, Immunoblot, Immunoturbidimetry, Spectrophotometry

Test Type: Disorders of Respiratory System

Doctor: Physician, Chest Physician

Test Department: IMMUNOPATHOLOGY

Pre Test Information: No special preparation required

Test Details:

The AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL test is a diagnostic tool used to evaluate and diagnose autoimmune interstitial lung diseases. This panel includes a combination of specific blood tests that help identify antibodies and markers associated with various autoimmune conditions that can affect the lungs.

Some of the tests included in this panel may include:

  1. Antinuclear Antibodies (ANA): This test detects the presence of antibodies that target the nucleus of cells. ANA can be found in various autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and scleroderma.
  2. Rheumatoid Factor (RF): This test measures the presence of antibodies directed against the Fc portion of immunoglobulin G (IgG). It is commonly used to diagnose rheumatoid arthritis but can also be elevated in other autoimmune conditions.
  3. Anti-Jo-1 Antibodies: This test detects the presence of antibodies against Jo-1, an enzyme found in the cytoplasm of cells. Elevated levels of anti-Jo-1 antibodies are associated with autoimmune conditions like polymyositis and dermatomyositis, which can affect the lungs.
  4. Anti-CCP Antibodies: This test detects the presence of antibodies against cyclic citrullinated peptides (CCP). Elevated levels of anti-CCP antibodies are highly specific for rheumatoid arthritis and can be associated with lung involvement.
  5. Anti-SSA and Anti-SSB Antibodies: These tests detect the presence of antibodies against Sjgren’s syndrome A (SSA) and Sjgren’s syndrome B (SSB) antigens. These antibodies are often found in patients with Sjgren’s syndrome, an autoimmune disease that can cause lung involvement.
  6. Anti-MDA5 Antibodies: This test detects the presence of antibodies against melanoma differentiation-associated protein 5 (MDA5). Elevated levels of anti-MDA5 antibodies are associated with dermatomyositis and can be associated with lung involvement.

These are just a few examples of the tests that may be included in the AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL. The specific tests ordered may vary depending on the suspected autoimmune condition and the patient’s symptoms and medical history. The results of these tests can help guide the diagnosis and treatment of autoimmune interstitial lung diseases.

Test Name AUTOIMMUNE INTERSTITIAL LUNG DISEASE ILD PANEL Test
Components *ANA / ANF, IFA (HEP-2) Reflexto ENA Profile*ANCA, IFA in dilutions *ANTI CCP*RA factor, serum *ACE
Price 2120.0 AED
Sample Condition 3 mL (2 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery Sample Mon through Sat by 11 am; Report Next day
Method CMIA, IFA, Immunoblot, Immunoturbidimetry, Spectrophotometry
Test type Disorders of Respiratory System
Doctor Physician, Chest Physician
Test Department: IMMUNOPATHOLOGY
Pre Test Information No special preparation required
Test Details

The AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL test is a diagnostic tool used to evaluate and diagnose autoimmune interstitial lung diseases. This panel includes a combination of specific blood tests that help identify antibodies and markers associated with various autoimmune conditions that can affect the lungs.

Some of the tests included in this panel may include:

1. Antinuclear Antibodies (ANA): This test detects the presence of antibodies that target the nucleus of cells. ANA can be found in various autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and scleroderma.

2. Rheumatoid Factor (RF): This test measures the presence of antibodies directed against the Fc portion of immunoglobulin G (IgG). It is commonly used to diagnose rheumatoid arthritis but can also be elevated in other autoimmune conditions.

3. Anti-Jo-1 Antibodies: This test detects the presence of antibodies against Jo-1, an enzyme found in the cytoplasm of cells. Elevated levels of anti-Jo-1 antibodies are associated with autoimmune conditions like polymyositis and dermatomyositis, which can affect the lungs.

4. Anti-CCP Antibodies: This test detects the presence of antibodies against cyclic citrullinated peptides (CCP). Elevated levels of anti-CCP antibodies are highly specific for rheumatoid arthritis and can be associated with lung involvement.

5. Anti-SSA and Anti-SSB Antibodies: These tests detect the presence of antibodies against Sjgren’s syndrome A (SSA) and Sjgren’s syndrome B (SSB) antigens. These antibodies are often found in patients with Sjgren’s syndrome, an autoimmune disease that can cause lung involvement.

6. Anti-MDA5 Antibodies: This test detects the presence of antibodies against melanoma differentiation-associated protein 5 (MDA5). Elevated levels of anti-MDA5 antibodies are associated with dermatomyositis and can be associated with lung involvement.

These are just a few examples of the tests that may be included in the AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL. The specific tests ordered may vary depending on the suspected autoimmune condition and the patient’s symptoms and medical history. The results of these tests can help guide the diagnosis and treatment of autoimmune interstitial lung diseases.